Northern Trust
DERM icon

Northern Trust’s Journey Medical DERM Stock Holding History

Northern Trust’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$703K Buy
149,978
+56,309
+60% +$437K ﹤0.01% 3480
2025
Q4 		$722K Buy
93,669
+927
+1% +$7.27K ﹤0.01% 3516
2025
Q3 		$660K Buy
92,742
+7,750
+9% +$56.2K ﹤0.01% 3555
2025
Q2 		$610K Buy
84,992
+67,733
+392% +$468K ﹤0.01% 3590
2025
Q1 		$102K Hold
17,259
– – ﹤0.01% 4110
2024
Q4 		$67.5K Sell
17,259
-395
-2% -$2.16K ﹤0.01% 4220
2024
Q3 		$99.7K Hold
17,654
– – ﹤0.01% 4056
2024
Q2 		$99.6K Hold
17,654
– – ﹤0.01% 4056
2024
Q1 		$65K Buy
17,654
+1,000
+6% +$4.35K ﹤0.01% 4181
2023
Q4 		$95.9K Buy
+16,654
New +$74.2K ﹤0.01% 4124

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust's DERM Position: Q1 2026 in Review

Northern Trust increased its Journey Medical (DERM) stake by 60% in Q1 2026, buying an estimated $437K and bringing the position to 149,978 shares worth $703K. The position accounts for ﹤0.01% of the portfolio, ranked #3480.

Northern Trust first reported a position in DERM in Q4 2023 and has held it in 10 quarters since. The position peaked at $722K in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Northern Trust held 149,978 shares of Journey Medical worth $703K as of Q1 2026.
  • Northern Trust bought 56,309 Journey Medical shares in Q1 2026, an estimated $437K.
  • Journey Medical made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3480 holding.
  • Northern Trust first reported a position in Journey Medical in Q4 2023 and has held it in 10 quarters since.
  • Northern Trust's Journey Medical position peaked at $722K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.